APA

Lahuerta J. J., Mateos M. V., Martínez-López J., Grande C., de la Rubia J., Rosiñol L., Sureda A., García-Laraña J., Díaz-Mediavilla J., Hernández-García M. T., Carrera D., Besalduch J., de Arriba F., Oriol A., Escoda L., García-Frade J., Rivas-González C., Alegre A., Bladé J. & San Miguel J. F. (20110210). Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. : Haematologica.

Chicago

Lahuerta Juan José, Mateos Maria Victoria, Martínez-López Joaquin, Grande Carlos, de la Rubia Javier, Rosiñol Laura, Sureda Anna, García-Laraña José, Díaz-Mediavilla Joaquín, Hernández-García Miguel T, Carrera Dolores, Besalduch Joan, de Arriba Felipe, Oriol Albert, Escoda Lourdes, García-Frade Javier, Rivas-González Concepción, Alegre Adrían, Bladé Joan and San Miguel Jesús F. 20110210. Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. : Haematologica.

Harvard

Lahuerta J. J., Mateos M. V., Martínez-López J., Grande C., de la Rubia J., Rosiñol L., Sureda A., García-Laraña J., Díaz-Mediavilla J., Hernández-García M. T., Carrera D., Besalduch J., de Arriba F., Oriol A., Escoda L., García-Frade J., Rivas-González C., Alegre A., Bladé J. and San Miguel J. F. (20110210). Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. : Haematologica.

MLA

Lahuerta Juan José, Mateos Maria Victoria, Martínez-López Joaquin, Grande Carlos, de la Rubia Javier, Rosiñol Laura, Sureda Anna, García-Laraña José, Díaz-Mediavilla Joaquín, Hernández-García Miguel T, Carrera Dolores, Besalduch Joan, de Arriba Felipe, Oriol Albert, Escoda Lourdes, García-Frade Javier, Rivas-González Concepción, Alegre Adrían, Bladé Joan and San Miguel Jesús F. Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. : Haematologica. 20110210.